AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site H69del/V70del
Virus SARS-CoV-2
Mutation level Amino acid level
Gene/protein/region type S
Gene ID 43740568
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants Alpha
Viral reference sequence
Drug/antibody/vaccine -
Transmissibility promote
Transmission mechanism In addition, replacement of the H69 and V70 residues in the Alpha variant B.1.1.7 spike (where delH69/V70 occurs naturally) impairs spike incorporation and entry efficiency of the B.1.1.7 spike pseudotyped virus. Alpha variant B.1.1.7 spike mediates faste
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Spike glycoprotein
Uniprot protein ID P0DTC2
Protein length 1273 amino acids
Protein description Spike protein is one of the structural proteins of SARS-CoV-2. The monomeric protein consists of one large ectodomain, a single-pass transmembrane anchor, and a short intracellular tail at C-terminus. It encompasses 22 glycosylation sites. S protein cleaves into two subunits namely S1 and S2 following receptor recognition. Receptor Binding Domain (RBD) in S1 subunit plays a major role in ACE2 receptor binding.

Literature information:


Pubmed ID 34166617
Clinical information No
Disease -
Published year 2021
Journal Cell Reports
Title Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Author Bo Meng, Steven A Kemp, Guido Papa, Rawlings Datir, Isabella A T M Ferreira
Evidence We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike delH69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape